Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Fulcrum Therapeutics Inc FULC

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. The Company’s clinical product candidate, losmapimod, is developed for the potential treatment of facioscapulohumeral muscular dystrophy (FSHD). Its other clinical product candidate is FTX... see more

Recent & Breaking News (NDAQ:FULC)

Bronstein, Gewirtz & Grossman, LLC Encourages Fulcrum Therapeutics, Inc. (FULC) Shareholders to Inquire about Securities Investigation

ACCESS Newswire September 24, 2024

Lost Money on Fulcrum Therapeutics, Inc.(FULC)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

ACCESS Newswire September 23, 2024

The Schall Law Firm Is Investigating Fulcrum Therapeutics, Inc. For Possible Securities Law Violations And Stockholders With Losses Are Urged To Reach Out

ACCESS Newswire September 23, 2024

Levi & Korsinsky Reminds Fulcrum Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities Laws - FULC

ACCESS Newswire September 23, 2024

FULC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Fulcrum Therapeutics, Inc. and Encourages Investors to Contact the Firm!

PR Newswire September 23, 2024

Shareholders that Lost Money on Fulcrum Therapeutics, Inc. (FULC) Should Contact Levi & Korsinsky About Securities Fraud Investigation - FULC

ACCESS Newswire September 23, 2024

Fulcrum Therapeutics, Inc. (FULC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation!

ACCESS Newswire September 23, 2024

Fulcrum Therapeutics, Inc. (FULC) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

ACCESS Newswire September 22, 2024

Fulcrum Therapeutics Inc May Have Engaged In Securities Fraud And The Schall Law Firm Encourages Affected Investors To Join An Inquiry

ACCESS Newswire September 22, 2024

FULC ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Fulcrum Therapeutics, Inc. Shareholders Who Lost Money

ACCESS Newswire September 22, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Fulcrum Therapeutics, Inc. (FULC) And Encourages Investors to Connect

ACCESS Newswire September 22, 2024

Fulcrum Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - FULC

ACCESS Newswire September 21, 2024

The Schall Law Firm Is Investigating Whether Fulcrum Therapeutics, Inc. Violated Securities Laws And Stockholders With Losses Are Invited To Reach Out

ACCESS Newswire September 21, 2024

Fulcrum Therapeutics Inc Is Being Looked Into For Securities Fraud And The Schall Law Firm Seeks Impacted Shareholders To Join The Inquiry

ACCESS Newswire September 20, 2024

Did Fulcrum Therapeutics, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - FULC

ACCESS Newswire September 20, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Fulcrum Therapeutics, Inc. (FULC) Stockholders to Inquire about Securities Investigation

ACCESS Newswire September 20, 2024

Shareholder Rights Advocates at Levi & Korsinsky Investigate Fulcrum Therapeutics, Inc. (FULC) Regarding Possible Securities Fraud Violations

ACCESS Newswire September 19, 2024

The Schall Law Firm Has Launched An Investigation Into Possible Securities Law Violations By Fulcrum Therapeutics, Inc. And Investors Are Invited To Take Part

ACCESS Newswire September 19, 2024

Fulcrum Therapeutics, Inc. Being Investigated on Behalf of Fulcrum Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details

ACCESS Newswire September 19, 2024

ATTENTION Fulcrum Therapeutics, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights

ACCESS Newswire September 19, 2024